DEXAMETHASONE SODIUM PHOSPHATE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F6998 to DMS Pharmaceutical Group Inc (CAGE 1UNB0) on July 2, 2026, for the procurement of Dexamethasone Sodium Phosphate Injection (NSN 6505015989257). This award, issued as a delivery order under SPE2DX25D9900, has a total fixed price of $141.89 for one package. The contractor is responsible for the manufacturing, labeling, and packaging of the pharmaceutical product in accordance with FDA regulations and military specifications. Delivery is required by July 17, 2026, to Cannon AFB, New Mexico. The contract is established with FOB Destination terms, meaning the contractor bears the cost and risk of transport and is responsible for shipping via traceable means, as parcel post is explicitly prohibited. Both inspection and acceptance will occur at the destination. The award allows for zero quantity variance and specifies that medical substitution is permitted.
General Info
Contract Value
$141.89Place of Performance
IL, USASet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
